| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| 1 | 08-07-2025 | 06-30-2025 | 10-Q |
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
UBS analyst Marcus Cole maintains Amrize (NYSE:AMRZ) with a Neutral and raises the price target from $49 to $52.
Wells Fargo analyst Timna Tanners initiates coverage on Amrize (NYSE:AMRZ) with a Overweight rating and announces Price Targ...
Darden, Humana, Rocket Lab, and FactSet led last week's large-cap losers, with declines driven by weak earnings, guidance, ...
Oppenheimer analyst Bryan Blair initiates coverage on Amrize (NYSE:AMRZ) with a Outperform rating and announces Price Target...